The Medicine Accelerator


The Medicine Accelerator, the Irish Multinational group responsible for breakthrough process research and development (APC) and Manufacture (VLE), helps biopharma companies slash drug development times by delivering breakthrough science at lightning-fast process development speed. We thrive on radical collaboration – challenging ourselves and our clients to deliver for patients faster by prioritizing best-in-class science, first-in-class digital and science-first manufacturing.
APC was founded in 2011 by Dr. Mark Barrett and Prof. Brian Glennon of the UCD School of Chemical Bioprocess Engineering in Dublin, Ireland, who embarked on a mission to disrupt the pharma and biotech industries with a hyper-focused, accelerated approach to drug process development. Foregoing outside investment, APC has grown organically to become a global powerhouse in process development, partnering with companies large & small to bring medicines to market at unprecedented speed.
VLE Therapeutics was established, by APC’s shareholders, as a sister company to APC in 2021 to transform the manufacture of advanced biotherapeutics and vaccines. VLE leverages industry-first digitalization and scientific breakthroughs to transform the time and cost to manufacture these lifesaving medicines. Through the extension of APC’s research value chain, VLE & APC have created The Medicine Accelerator where time to patient is transformed through breakthrough science, digitization & manufacture.

Get Involved with the Advanced Therapies Congress


To sponsor or exhibit

Ashlea Foster
+44 208 164 3032



To speak

Ila Dickinson
+44 207 092 1150